The Cigna Group announced it will release its third quarter 2026 financial results on Thursday, November 5, 2026. The global health company plans to publish the data no later than 6:30 am Eastern Time.

Management will review the results during a conference call scheduled for 8:30 am ET on the same day. Participants are advised to dial in by 8:15 am ET to ensure connection. The call will be available via live internet webcast on the company's investor relations website.

Access details for investors

A replay of the conference call will be accessible from 12:30 pm ET on November 5, 2026, until 10:59 pm ET on November 19, 2026. The live webcast and subsequent replay can be accessed through the events and presentations section of the company's website.

The company's news release and financial supplement will be posted on its website in the Investor Relations section no later than 6:30 am ET on November 5, 2026. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, serving over 180 million customer relationships globally.

The Obesity Action Coalition (OAC) is calling on the Cigna Group to reconsider its decision to end coverage of GLP-1 medications for weight management. The advocacy group argues that the company must listen to its workforce, which has expressed significant concern over the loss of access to these treatments.

In June, Cigna notified more than 50,000 U.S. employees that its health plan would stop covering GLP-1 medications for weight management. The decision took effect on July 1, prompting an immediate response from staff. Almost 600 employees signed a petition asking the company to reinstate the coverage, highlighting the personal impact of the policy change.

Employee financial burden increases

Despite the internal backlash, Cigna has maintained its position. In a statement to Bloomberg Businessweek, the company said the decision was made carefully based on research and input from leaders across the organization, including clinical leaders. Cigna also pointed to health coaching and other resources as alternative support mechanisms for weight management.

However, the financial impact on employees is already evident. Reports indicate that some staff members are now forced to pay hundreds of dollars out of pocket for medications they previously accessed through employer-sponsored plans. One employee reported costs jumping from $25 a month before coverage ended to approximately $300 a month afterward.

Advocacy stance on chronic disease care

Joe Nadglowski, President and CEO of OAC, stated that Cigna employees have spoken and the company needs to listen. "These are not simply numbers on a benefits spreadsheet," Nadglowski said. "These are people living with a chronic disease who are telling their employer that access to their treatment matters."

The OAC emphasizes that obesity is a chronic disease that may require long-term treatment. While acknowledging the value of health coaching and lifestyle support, the coalition argues these should not substitute for medically appropriate treatment prescribed by a health care provider. The group urges Cigna to ensure people living with obesity have access to science-based treatment options.

What the numbers show

The disparity between the number of affected employees (50,000) and the number who signed the petition (600) suggests that while vocal opposition exists, it represents a small fraction of the total workforce impacted by the benefit change. Furthermore, the shift in monthly costs from $25 to $300 represents a 12-fold increase in out-of-pocket expenses for individual patients, illustrating the significant financial barrier created by the removal of insurance coverage.